Literature DB >> 2988830

Immunoglobulin G subclass antibody responses in influenza A and parainfluenza type 1 virus infections.

I Julkunen, T Hovi, I Seppälä, O Mäkelä.   

Abstract

Antibody responses in immunoglobulin G1, G2, G3, G4, A (IgA1) and M isotypes were studied in 10 patients with an acute influenza A and in another 10 patients with a parainfluenza type 1 virus infection using radioimmunoassay with standardized monoclonal anti-immunoglobulins. A four-fold or greater increase of antibody in patients have an acute influenza A virus infection, were found in IgG1 (all 10 cases), IgG3 (seven cases), IgG4 (eight cases) and in IgA1 (six cases) whereas IgG2 and IgM responses were observed only in one and three cases, respectively. The antibody titre values were converted to immunoglobulin units by multiplying the titre by a pre-determined correction coefficient compensating for the varying affinity of the individual monoclonal anti-immunoglobulins. These units were then used to calculate the actual proportions of each isotype. In the convalescent phase, 78% of total anti-influenza A antibodies were estimated to be of IgG1 isotype and other immunoglobulin isotypes varied from 3 to 7% of total. Similar results in parainfluenza virus antibodies were obtained with serum pairs from patients with an acute parainfluenza virus infection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988830      PMCID: PMC1577008     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  IgG1 subclass restriction of oligoclonal measles virus-specific IgG antibodies in patients with subacute sclerosing panencephalitis and in a patient with multiple sclerosis.

Authors:  B Vandvik; J B Natvig; E Norrby
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

2.  Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy.

Authors:  M van der Giessen; W L Homan; G van Kernbeek; R C Aalberse; P H Dieges
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

3.  Improved methods for separation and purification by affinity chromatography.

Authors:  G Johnson; J S Garvey
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

4.  Interaction of viral envelope glycoproteins with fibronectin.

Authors:  I Julkunen; A Hautanen; J Keski-Oja
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

5.  IgG1 is the predominant subclass of in vivo- and in vitro- produced anti-tetanus toxoid antibodies and also serves as the membrane IgG molecule for delivering inhibitory signals to anti-tetanus toxoid antibody-producing B cells.

Authors:  R Stevens; D Dichek; B Keld; D Heiner
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

6.  Immunoglobulin G subclass restriction of antibodies against hepatitis B surface antigen.

Authors:  A Morell; B Roth-Wicky; F Skvaril
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

7.  Predominance of immunoglobulin G sub-class 3 among the complement-fixing antibodies to streptococcal M-associated protein.

Authors:  G E Mortimer; J P Widdowson
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

8.  Natural infection of man with group A streptococci. Levels; restriction in class, subclass, and type; and clonal appearance of polysaccharide-group-specific antibodies.

Authors:  W F Riesen; F Skvaril; D G Braun
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

9.  The subclasses of human IgG antibodies against tetanus toxoid.

Authors:  M van der Giessen; O Groenboer-Kempers
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

10.  Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers.

Authors:  W J Yount; M M Dorner; H G Kunkel; E A Kabat
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  8 in total

1.  Immunoglobulin G, A and M response to influenza vaccination in different age groups: effects of priming and boosting.

Authors:  W E Beyer; J T Van der Logt; R van Beek; N Masurel
Journal:  J Hyg (Lond)       Date:  1986-06

2.  Differential immunoglobulin G subclass antibody titers to respiratory syncytial virus F and G glycoproteins in adults.

Authors:  D K Wagner; D L Nelson; E E Walsh; C B Reimer; F W Henderson; B R Murphy
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

3.  Proportions of immunoglobulin isotypes in paralytic poliomyelitis and after vaccination.

Authors:  I Julkunen; P Ukkonen; M Stenvik; T Hovi; L Renkonen; O Mäkelä
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

Review 4.  Biology of parainfluenza viruses.

Authors:  R Vainionpää; T Hyypiä
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

Review 5.  Parainfluenza viruses.

Authors:  Kelly J Henrickson
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

6.  Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection.

Authors:  D K Wagner; B S Graham; P F Wright; E E Walsh; H W Kim; C B Reimer; D L Nelson; R M Chanock; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

7.  Low quality antibody responses in critically ill patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection.

Authors:  Xiuhua Lu; Zhu Guo; Zhu-Nan Li; Crystal Holiday; Feng Liu; Stacie Jefferson; F Liaini Gross; Wen-Ping Tzeng; Anand Kumar; Ian A York; Timothy M Uyeki; Terrence Tumpey; James Stevens; Min Z Levine
Journal:  Sci Rep       Date:  2022-09-02       Impact factor: 4.996

8.  Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011-2012 influenza vaccine season.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Nicholas V Mendez; Ana Marie Landin; Bonnie B Blomberg
Journal:  Immun Ageing       Date:  2013-04-22       Impact factor: 6.400

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.